Redwood Financial Network Corp Has $841,000 Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Redwood Financial Network Corp trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,415 shares of the biotechnology company’s stock after selling 15 shares during the period. Redwood Financial Network Corp’s holdings in Axon Enterprise were worth $841,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of AXON. Artemis Investment Management LLP boosted its position in shares of Axon Enterprise by 21.4% during the 4th quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock valued at $56,528,000 after purchasing an additional 16,792 shares in the last quarter. Decker Retirement Planning Inc. acquired a new position in Axon Enterprise in the fourth quarter valued at approximately $2,985,000. Perigon Wealth Management LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $488,000. Czech National Bank grew its position in shares of Axon Enterprise by 7.4% during the 4th quarter. Czech National Bank now owns 15,707 shares of the biotechnology company’s stock worth $9,335,000 after buying an additional 1,082 shares during the period. Finally, Hennion & Walsh Asset Management Inc. increased its stake in shares of Axon Enterprise by 26.8% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 7,169 shares of the biotechnology company’s stock valued at $4,261,000 after acquiring an additional 1,517 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Insider Transactions at Axon Enterprise

In related news, Director Matthew R. Mcbrady sold 400 shares of the firm’s stock in a transaction dated Wednesday, May 14th. The shares were sold at an average price of $718.40, for a total transaction of $287,360.00. Following the completion of the sale, the director now owns 3,492 shares in the company, valued at approximately $2,508,652.80. This trade represents a 10.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Brittany Bagley sold 3,400 shares of Axon Enterprise stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the completion of the sale, the chief financial officer now directly owns 131,833 shares in the company, valued at approximately $92,283,100. This represents a 2.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 23,764 shares of company stock worth $14,856,635 in the last ninety days. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Up 0.5%

AXON stock opened at $728.53 on Thursday. The firm has a market capitalization of $56.72 billion, a PE ratio of 188.25, a P/E/G ratio of 5.17 and a beta of 1.24. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $732.17. The stock’s 50 day moving average is $576.22 and its 200-day moving average is $589.48.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business had revenue of $603.63 million for the quarter, compared to analysts’ expectations of $585.67 million. During the same period last year, the business earned $1.15 EPS. The business’s revenue was up 31.3% on a year-over-year basis. Sell-side analysts expect that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently issued reports on AXON shares. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Barclays upped their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a report on Friday, May 9th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a research report on Wednesday. Needham & Company LLC boosted their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a research report on Thursday, May 8th. Finally, JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $652.73.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.